Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-09-28 09:00 |
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Applic…
|
Dutch | 319.4 KB | ||
| 2022-09-28 09:00 |
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Applic…
|
English | 280.4 KB | ||
| 2022-09-23 10:45 | English | 509.4 KB | |||
| 2022-08-04 08:10 |
Pharming Group reports financial results for the first half of 2022
|
English | 761.4 KB | ||
| 2022-08-04 08:10 |
Pharming Group reports financial results for the first half of 2022
|
English | 739.8 KB | ||
| 2022-08-02 08:01 |
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
|
English | 145.6 KB | ||
| 2022-08-02 08:01 |
Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency
|
English | 142.8 KB | ||
| 2022-08-01 09:39 |
Pharming Group krijgt versnelde beoordeling in Europa voor leniolisib ter behan…
|
Dutch | 286.4 KB | ||
| 2022-08-01 08:51 |
Pharming Group Receives Accelerated Assessment in Europe for leniolisib for the…
|
English | 260.9 KB | ||
| 2022-06-02 15:04 |
Pharming Group presenteert tijdens de Jefferies Healthcare Conference
|
English | 192.8 KB | ||
| 2022-06-02 15:04 |
Pharming Group presenteert tijdens de Jefferies Healthcare Conference
|
Dutch | 191.1 KB | ||
| 2022-05-19 08:30 |
Pharming Press release AGM 2022
|
Dutch | 185.8 KB | ||
| 2022-05-19 08:30 |
Pharming Press release AGM 2022
|
English | 170.2 KB | ||
| 2022-05-12 08:52 |
Pharming Q1 resultaten 2022
|
Dutch | 298.8 KB | ||
| 2022-05-12 08:52 |
Pharming Q1 resultaten 2022
|
Dutch | 303.9 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
